查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1577298

肠内饲管市场、机会、成长动力、产业趋势分析与预测，2024-2032

Enteral Feeding Tubes Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3个工作天内

价格
简介目录

受肠内餵食技术进步、慢性病患病率上升、人口老化、早产率上升以及家庭医疗保健采用趋势不断增长的推动，2024年至2032年全球肠内饲管市场将增长6.3%，除其他因素外。

推动肠内饲管产业成长的因素包括技术进步、人口老化和慢性病的增加。随着医疗保健技术的发展，肠内餵食方法变得更加高效和用户友好，从而导致越来越多的采用。全球慢性病的增加，尤其是人口老化，需要营养支持，进一步推动市场成长。此外，早产的激增和家庭医疗保健采用的成长趋势凸显了对肠内餵食解决方案的需求不断扩大。

肠饲管市场根据产品、疾病状况、病人、管类型、管放置、最终用途和地区进行分类。

市场将产品分为鼻肠/鼻饲管和腹部/造口饲管。鼻肠/鼻饲管段包括鼻胃管和鼻空肠管，而腹部/造口段包括胃造口管、空肠造口/空肠管和胃空肠管(GJ)或经空肠管。鼻肠/鼻饲管领域在 2023 年以 17 亿美元的收入引领市场。这使它们成为各种临床情况下临时营养支持的理想选择。此外，加护病房 (ICU) 中的患者通常无法口服进食，因此越来越依赖鼻肠饲管。这一趋势是由重症疾病和手术导致的 ICU 入院率上升所推动的，凸显了该细分市场的成长。

市场根据疾病状况对肠内饲管进行分类，包括癌症、中枢神经系统 (CNS) 和心理健康问题、非恶性胃肠道 (GI) 疾病等。癌症细分市场进一步分为头颈癌、胃肠道癌和其他癌症，到2023 年将占48% 的肠内饲管市场份额。 。随着癌症治疗的进步提高了存活率，对长期营养支持的需求激增，推动了该领域的成长。

2023年北美肠内饲管市场规模达8.762亿美元，预计2024年至2032年复合年增长率为5.9%。 。改进的饲管设计和高效的饲管等创新提高了采用率。此外，经常面临先天畸形和严重疾病的儿科患者对肠内餵食的需求更高。这种针对弱势儿科族群的特殊营养需求进一步推动了区域市场的成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 全球癌症病例数增加
      • 早产和儿科疾病发生率上升
      • 中枢神经系统发育和心理健康障碍
      • 增加代谢紊乱
      • 最近的技术进步
      • 家庭医疗保健采用率上升
    • 产业陷阱与挑战
      • 发展中和欠发达地区缺乏认识
      • 与肠内餵食相关的风险
  • 成长潜力分析
  • 监管环境
  • 差距分析
  • 技术景观
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 鼻肠/鼻饲管
    • 鼻胃管
    • 鼻空肠管
  • 腹部/造口饲管
    • 胃造口管
    • 空肠造口/空肠管
    • 胃空肠 (GJ) 或经空肠管

第 6 章：市场估计与预测：按疾病状况，2021 - 2032 年

  • 主要趋势
  • 癌症
    • 头颈癌
    • 胃肠癌
    • 其他癌症
  • 中枢神经系统（CNS）和心理健康
  • 非恶性胃肠道 (GI) 疾病
  • 其他疾病状况

第 7 章：市场估计与预测：按患者分类，2021 - 2032 年

  • 主要趋势
  • 成人
  • 儿科

第 8 章：市场估计与预测：按管类型，2021 - 2032

  • 主要趋势
  • 短期饲管
  • 长期饲管
  • 临时饲管

第 9 章：市场估计与预测：按管布置，2021 - 2032 年

  • 主要趋势
  • 无需手术
  • 手术放置
  • 内视镜放置

第 10 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 居家护理
  • 医院
  • 其他最终用户

第 11 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 12 章：公司简介

  • Abbott Laboratories
  • Applied Medical Technology, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • Cardinal Health
  • CONMED Corporation
  • Cook Medical
  • Danone SA
  • Fresenius Kabi AG
  • Medline Industries, Inc.
  • MOOG Inc.
  • Vygon
简介目录
Product Code: 4846

The Global Enteral Feeding Tubes Market will witness a 6.3% from 2024 to 2032, driven by advancements in enteral feeding technology, a rising prevalence of chronic diseases, an aging population, an uptick in preterm births, and a growing trend towards home healthcare adoption, among other factors.

Factors driving the growth of the enteral feeding tubes industry include technological advancements, an aging population, and a rise in chronic diseases. As healthcare technology evolves, enteral feeding methods become more efficient and user-friendly, leading to increased adoption. The global rise in chronic diseases, especially in aging populations, necessitates nutritional support, further propelling market growth. Additionally, the surge in preterm births and the growing trend of home healthcare adoption underscore the expanding demand for enteral feeding solutions.

The Enteral Feeding Tubes Market is categorized based on product, disease condition, patient, tube type, tube placement, end use , and region.

The market categorizes products into nasoenteric/nasal feeding tubes and abdominal/ostomy feeding tubes. The nasoenteric/nasal feeding tube segment includes nasogastric and nasojejunal tubes, while the abdominal/ostomy segment encompasses gastrostomy, jejunostomy/jejunal, and gastrojejunal (GJ) or transjejunal tubes. The nasoenteric/nasal feeding tube segment led the market with a revenue of USD 1.7 billion in 2023. Nasoenteric tubes, favored for short-term feeding (typically under four weeks), are less invasive than other methods. This makes them ideal for temporary nutritional support across various clinical scenarios. Moreover, patients in intensive care units (ICUs), often unable to eat orally, increasingly rely on nasoenteric feeding tubes. This trend, driven by rising ICU admissions from critical illnesses and surgeries, underscores the segment's growth.

The market classifies enteral feeding tubes based on disease conditions, including cancer, central nervous system (CNS) & mental health issues, non-malignant gastrointestinal (GI) disorders, and others. The cancer segment, further divided into head and neck, gastrointestinal, and other cancers, commanded a 48% enteral feeding tubes market share in 2023. Treatments like chemotherapy and radiation can induce side effects such as nausea and difficulty swallowing. With advancements in cancer treatments boosting survival rates, the demand for long-term nutritional support has surged, propelling the segment's growth.

North America enteral feeding tubes market accounted for USD 876.2 million in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2032. As a frontrunner in healthcare innovation, North America has been pivotal in advancing enteral feeding technologies. Innovations, including enhanced feeding tube designs and efficient feeding pumps, have spurred adoption rates. Additionally, pediatric patients, often facing congenital abnormalities and severe illnesses, have a heightened need for enteral feeding. This specialized nutritional demand for vulnerable pediatric populations has further fueled the regional market growth.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increase in number of cancer cases across the globe
      • 3.2.1.2 Rise in incidence of premature births and pediatric diseases
      • 3.2.1.3 Growing central nervous system and mental health disorders
      • 3.2.1.4 Increasing metabolic disorders
      • 3.2.1.5 Recent technological advancements
      • 3.2.1.6 Rise in adoption of home healthcare
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Lack of awareness in developing and under-developed regions
      • 3.2.2.2 Risks associated with enteral feeding
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Gap analysis
  • 3.6 Technology landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Nasoenteric/nasal feeding tube
    • 5.2.1 Nasogastric tube
    • 5.2.2 Nasojejunal tube
  • 5.3 Abdominal/ostomy feeding tube
    • 5.3.1 Gastrostomy tube
    • 5.3.2 Jejunostomy/jejunal tube
    • 5.3.3 Gastrojejunal (GJ) or transjejunal tube

Chapter 6 Market Estimates and Forecast, By Disease Condition, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cancer
    • 6.2.1 Head and neck cancer
    • 6.2.2 Gastrointestinal cancer
    • 6.2.3 Other cancers
  • 6.3 Central nervous system (CNS) and mental health
  • 6.4 Non-malignant gastrointestinal (GI) disorders
  • 6.5 Other disease conditions

Chapter 7 Market Estimates and Forecast, By Patient, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Adult
  • 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By Tube Type, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Short term feeding tube
  • 8.3 Long term feeding tube
  • 8.4 Temporary feeding tube

Chapter 9 Market Estimates and Forecast, By Tube Placement, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Without surgery
  • 9.3 Surgical placement
  • 9.4 Endoscopic placement

Chapter 10 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 Home care
  • 10.3 Hospitals
  • 10.4 Other end-users

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 11.1 Key trends
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Netherlands
    • 11.3.7 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 South Korea
    • 11.4.6 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
    • 11.5.4 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 UAE
    • 11.6.4 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 Abbott Laboratories
  • 12.2 Applied Medical Technology, Inc.
  • 12.3 Avanos Medical, Inc.
  • 12.4 B. Braun Melsungen AG
  • 12.5 Becton, Dickinson and Company
  • 12.6 Boston Scientific Corporation
  • 12.7 C.R. Bard, Inc.
  • 12.8 Cardinal Health
  • 12.9 CONMED Corporation
  • 12.10 Cook Medical
  • 12.11 Danone S.A.
  • 12.12 Fresenius Kabi AG
  • 12.13 Medline Industries, Inc.
  • 12.14 MOOG Inc.
  • 12.15 Vygon